Medical Instruments & Supplies Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
Current Valuation | Efficiency | Market Risk | Exp Return | ||||
---|---|---|---|---|---|---|---|
1 | ATR | AptarGroup | (0.17) | 1.44 | (0.24) | ||
2 | AVR | Anteris Technologies Global | 0.12 | 4.16 | 0.48 | ||
3 | NEPH | Nephros | 0.04 | 2.61 | 0.10 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.